Megan Keller, PhD
Megan Keller is a freelance science writer finishing her PhD in Microbiology at Cornell University. She aspires to be the bridge between bench work and dinner table conversations, connecting science to our daily lives. She was the Fall 2022 Communications Intern for Cell Press and her work has appeared in Science, The Conversation, and MicroBites. She enjoys hiking, reading books, crocheting, and all things cozy.
Articles by Megan Keller, PhD
| 4 min read
Explore the link between GLP-1 drugs and cancer. A new study reveals these therapies may reduce the risk of obesity-related cancers, similar to bariatric surgery.
| 3 min read
A new antifungal drug, mandimycin, tackles resistant fungal strains with a never-before-seen mechanism that avoids kidney toxicity.
| 4 min read
A strain of E. coli linked to Crohn’s disease produces a compound that triggers intestinal scarring, revealing a potential treatment path.
| 4 min read
The general anesthesia drug propofol restores function to mutated signaling channels associated with epilepsy.
| 4 min read
A new wound dressing monitors infections in real time and administers timely treatment using metal ions.
| 4 min read
By identifying the types of molecules that accumulate inside P. aeruginosa, researchers drew a roadmap for new antibiotic development for combatting these deadly pathogens.
| 3 min read
Since antibiotics tend to have negative side effects on the gut, researchers sought an alternative in an unexpected place: yogurt.
Page 1 of 1 - 7 Total Items
